Clinical Trial Update: A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports on a regimen including bedaquiline with clarithromycin and ethambutol for adults with treatment-refractory MAC lung disease, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Avium Complex Lung Disease

Drugs mentioned

• Ethambutol (ethambutol)
• bedaquiline (bedaquiline)
• clarithromycin (clarithromycin)

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2026-04-15